Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 71:
72. The compound of claim 71, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2f is C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein the C1-C6 alkyl, C3-C8 cycloalkyl, 3- to 12-membered heterocyclyl, C6-C14 aryl, or 5- to 10-membered heteroaryl is optionally substituted by 1 or more independently selected R2i substituents; and
each R2i is optionally and independently substituted by 1 or more independently selected R4a substituents.